Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Clinical trial NCT00919061 · COMPLETED
Trial details
- NCT number
- NCT00919061
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2014-03-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.